Friedenthal Financial Makes New Investment in HCA Healthcare, Inc. $HCA

Friedenthal Financial bought a new stake in shares of HCA Healthcare, Inc. (NYSE:HCAFree Report) during the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund bought 2,067 shares of the company’s stock, valued at approximately $978,000.

Several other large investors have also made changes to their positions in HCA. Holos Integrated Wealth LLC bought a new position in shares of HCA Healthcare in the fourth quarter worth about $29,000. Palisade Asset Management LLC purchased a new position in HCA Healthcare in the 3rd quarter worth approximately $26,000. Ares Financial Consulting LLC purchased a new stake in HCA Healthcare during the 4th quarter valued at approximately $31,000. MCF Advisors LLC lifted its holdings in shares of HCA Healthcare by 213.0% in the fourth quarter. MCF Advisors LLC now owns 72 shares of the company’s stock worth $34,000 after buying an additional 49 shares in the last quarter. Finally, Aventura Private Wealth LLC purchased a new position in HCA Healthcare during the fourth quarter valued at $34,000. 62.73% of the stock is currently owned by hedge funds and other institutional investors.

HCA Healthcare News Summary

Here are the key news stories impacting HCA Healthcare this week:

HCA Healthcare Price Performance

NYSE:HCA opened at $388.38 on Thursday. The firm has a market capitalization of $86.16 billion, a price-to-earnings ratio of 13.36, a PEG ratio of 1.23 and a beta of 1.12. The business has a 50 day simple moving average of $412.73 and a 200-day simple moving average of $466.54. HCA Healthcare, Inc. has a 1 year low of $330.00 and a 1 year high of $556.52.

HCA Healthcare (NYSE:HCAGet Free Report) last issued its quarterly earnings results on Friday, April 24th. The company reported $7.15 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $7.19 by ($0.04). HCA Healthcare had a negative return on equity of 295.93% and a net margin of 8.89%.The company had revenue of $19.11 billion during the quarter, compared to the consensus estimate of $19.09 billion. During the same quarter in the prior year, the business earned $6.45 earnings per share. The firm’s quarterly revenue was up 4.3% compared to the same quarter last year. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. As a group, analysts expect that HCA Healthcare, Inc. will post 30.07 earnings per share for the current fiscal year.

HCA Healthcare Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 30th. Investors of record on Tuesday, June 16th will be given a $0.78 dividend. This represents a $3.12 dividend on an annualized basis and a yield of 0.8%. The ex-dividend date of this dividend is Tuesday, June 16th. HCA Healthcare’s dividend payout ratio is 10.73%.

Wall Street Analyst Weigh In

HCA has been the subject of several research reports. Royal Bank Of Canada dropped their price objective on shares of HCA Healthcare from $593.00 to $534.00 and set an “outperform” rating for the company in a report on Monday, April 27th. KeyCorp dropped their price target on HCA Healthcare from $550.00 to $510.00 and set an “overweight” rating for the company in a research note on Monday, April 27th. Wells Fargo & Company reduced their price objective on HCA Healthcare from $481.00 to $436.00 and set an “equal weight” rating on the stock in a research note on Monday, April 27th. Truist Financial set a $413.00 target price on shares of HCA Healthcare in a report on Thursday, June 4th. Finally, Sanford C. Bernstein decreased their price target on shares of HCA Healthcare from $503.00 to $413.00 and set a “market perform” rating on the stock in a research note on Thursday, June 4th. Fifteen analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $503.00.

View Our Latest Stock Report on HCA

HCA Healthcare Profile

(Free Report)

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.

Further Reading

Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCAFree Report).

Institutional Ownership by Quarter for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.